Table 2 Characteristics of kidney transplant patients with ESKD secondary to MPGN and all other glomerulonephritis (unmatched and propensity score matched patients)
Characteristic | Unmatched Cohort (n) | Matched Cohort (n) | ||
|---|---|---|---|---|
MPGN (n = 190) | All other GN (n = 5519) | MPGN (n = 188) | All other GN (n = 188) | |
Age (years) | 42 (29–51) | 44 (32–54) | 42 (31–53) | 44 (33–55) |
Male | 113 (59%) | 3613 (65%) | 111 (59%) | 111 (59%) |
Ethnicity | ||||
Caucasian | 147 (77%) | 4228 (77%) | 145 (77%) | 149 (79%) |
ATSI | 6 (3%) | 145 (3%) | 6 (3%) | 3 (2%) |
MPI | 21 (11%) | 256 (5%) | 21 (11%) | 20 (11%) |
Asian | 13 (7%) | 771 (14%) | 13 (7%) | 12 (6%) |
Other | 3 (2%) | 119 (2%) | 3 (2%) | 4 (2%) |
Transplant Era | ||||
96–06 | 97 (51%) | 2252 (41%) | 97 (52%) | 96 (51%) |
07–16 | 93 (49%) | 3267 (59%) | 91 (48%) | 92 (49%) |
Hepatitis C Antibody Positive | 15 (8%) | 50 (1%) | 13 (7%) | 12 (6%) |
Current Smoker | 29 (15%) | 572 (10%) | 28 (15%) | 31 (16%) |
Diabetes Mellitus | 14 (7%) | 267 (5%) | 12 (6%) | 8 (4%) |
Chronic Lung Disease | 7 (4%) | 227 (4%) | 7 (4%) | 8 (4%) |
Coronary Artery Disease | 9 (5%) | 338 (6%) | 9 (5%) | 11 (6%) |
Peripheral Vascular Disease | 3 (2%) | 93 (2%) | 3 (2%) | 4 (2%) |
Cerebrovascular Disease | 3 (2%) | 106 (2%) | 3 (2%) | 6 (3%) |
Cancer Diagnosis Ever | 7 (4%) | 161 (3%) | 7 (4%) | 9 (5%) |
First RRT Modality | ||||
HD | 127(67%) | 3435 (62%) | 125 (66%) | 125 (66%) |
PD | 48 (25%) | 1453 (26%) | 48 (26%) | 50 (27%) |
Pre-emptive Transplant | 15 (8%) | 631 (11%) | 15 (8%) | 13 (7%) |